During the ISSCR in Vancouver, Canada, 18-21 June 2014, Lonza will provide attendees with a comprehensive portfolio review of products and services that support stem-cell researchers from the laboratory bench to clinical applications. This offering will introduce Lonza’s L7 hiPSC Reprogramming and hPSC Culture System for stem-cell basic research, disease modelling, drug development and regenerative medicine.
On Thursday, 19 June, Lonza will host the Bridging Research to Therapy: Novel iPSC Tools and Technologies innovation showcase and will share the latest innovative technologies and tools to empower scientists conducting human stem-cell research. Three renowned speakers, Behnam Ahmadian Baghbaderani, Ph.D., Lonza Cell Therapy Development Services; Yu-Chieh Wang, Ph.D., Center for Regenerative Medicine, The Scripps Research Institute; and Linzhao Cheng, Ph.D., Institute for Cell Engineering, Johns Hopkins School of Medicine, will describe different approaches to overcome hiPSC challenges.
Also on Thursday, 19 June, two novel hPSC Culture System poster presentations will be held in the ISSCR exhibit area. Ashish Mehta, senior research scientist, National Heart Research Institute Singapore, will present Lonza L7 – An hPSC Culture System for Research and Future Clinical Applications. In parallel, Behnam Ahmadian Baghbaderani, Ph.D., from Lonza’s Cell Therapy Development Services, Lonza Walkersville, Inc., USA, will present Robust Generation and Maintenance of Human Induced Pluripotent Stem Cells Under Defined Xeno-Free Conditions.
ISSCR attendees have the opportunity to meet individually with Lonza experts to discuss a broad range of stem-cell research topics. Such expert topics include advances in nucleofector technology, L7 hPSC culture system and increasing biological relevance with primary cells and media.
